NanoViricides
NNVC
#10560
Rank
โ‚น3.47 B
Marketcap
โ‚น136.15
Share price
1.43%
Change (1 day)
8.86%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2026 (TTM): -โ‚น39.14

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น42.19. In 2025 the company made an earnings per share (EPS) of -โ‚น60.40 an increase over its 2024 EPS that were of -โ‚น67.12.

EPS history for NanoViricides from 2005 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น39.14-35.21%
2025-โ‚น60.40-10%
2024-โ‚น67.12-5.41%
2023-โ‚น70.955.71%
2022-โ‚น67.12-13.58%
2021-โ‚น77.66-66.11%
2020-โ‚น229.151.7%
2019-โ‚น225.32-10.98%
2018-โ‚น253.12-22.35%
2017-โ‚น325.99-10.53%
2016-โ‚น364.34375%
2015-โ‚น76.70-85.19%
2014-โ‚น517.7542.11%
2013-โ‚น364.3426.67%
2012-โ‚น287.64-6.25%
2011-โ‚น306.8114.28%
2010-โ‚น268.46100%
2009-โ‚น134.23-0%
2008-โ‚น134.23-33.33%
2007-โ‚น201.35-0%
2006-โ‚น201.354445.07%
2005-โ‚น4.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
โ‚น711.43-1,786.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น342.76-912.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น341.33-909.09%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น372.62-983.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-โ‚น51.78 22.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น165.87 293.18%๐Ÿ‡บ๐Ÿ‡ธ USA